✦ LIBER ✦

Prolonged remissions in adults with acute leukemia following late intensification chemotherapy and immunotherapy

✍ Scribed by Gerald P. Bodey; Emil J. Freireich; Kenneth B. McCredie; Jordan U. Gutterman; Evan M. Hersh; Terry L. Smith; Edmund A. Gehan

Publisher: John Wiley and Sons
Year: 1981
Tongue: English
Weight: 816 KB
Volume: 47
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19810415)47:8<1937::aid-cncr2820470804>3.0.co;2-g

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early intensification and short-term mai

Early intensification and short-term maintenance chemotherapy does not prolong survival in acute myelogenous leukemia

✍ Hagop M. Kantarjian; Michael J. Keating; Ronald S. Walters; Kenneth B. McCredie; 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 477 KB 👁 2 views

Impact of remission induction chemothera

Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia

✍ Rachid Baz; Cristina Rodriguez; Alex Z. Fu; Rony Abou Jawde; Matt Kalaycio; Anja 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Abstract ## BACKGROUND. Significant controversy surrounds the use of remission induction chemotherapy (IC) in older adults with acute myeloid leukemia (AML). Earlier clinical trials have yielded conflicting results and possibly a minor survival benefit, often offset by a longer hospitalization

Acute pulmonary failure during remission

Acute pulmonary failure during remission induction chemotherapy in adults with acute myeloid leukemia or high-risk myelodysplastic syndrome

✍ Ali Al Ameri; Charles Koller; Hagop Kantarjian; Farhad Ravandi; Srdan Verstovsek 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 2 views

Lithium treatment in adults with acute m

Lithium treatment in adults with acute myeloid leukemia receiving chemotherapy

✍ Horns, Richard C. ;Schrier, Stanley L. ;Greenberg, Peter L. 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 292 KB 👁 1 views

To determine whether lithium can shorten chemotherapy-induced neutropenia, 35 adult patients with newly diagnosed acute myeloid leukemia undergoing initial chemotherapy were randomized either to receive oral lithium started at the time of biopsy-proven hypoplasia or to receive no lithium. This study

Low dose interleukin-2 following intensi

Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission

✍ Richard M. Stone; Daniel J. DeAngelo; Anna Janosova; Ilene Galinsky; Christine C 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 343 KB 👁 2 views

## Abstract The most important problem in the therapy of patients with acute myeloid leukemia (AML) is relapse after intensive therapy. We sought to determine if interleukin‐2 (low‐dose with intermittent boluses) administration could be feasibly administered after standard therapy to potentiate ant

A randomized comparison of maintenance t

A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia: A leukemia-lymphoma group trial of the EORTC

✍ M. Hayat; U. Jehn; R. Willemze; C. Haanen; R. Zittoun; M. Monconduit; B. Lowenbe 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 624 KB